Skip to main content
. 2018 Mar 1;4:4. doi: 10.1186/s40780-018-0099-x

Table 3.

Self-reported oral effects of administration of pilocarpine solution to patients with Sjӧgren’s syndrome

Item VAS (10 cm) b
Pre-administration Post-administration at 60 min Continuous administration
Dryness 7.1 (6.1, 8.0) 4.4 (2.2, 6.5) a 3.7 (2.0, 6.9) a
Thirstiness 6.3 (4.5, 7.9) 2.3 (0.7, 5.4) a 2.4 (1.5, 5.3) a
Stickiness 6.3 (4.8, 7.4) 4.0 (0.7, 5.4) 2.4 (0.9, 6.5)
Altered taste 0.5 (0.3, 4.3) 1.1 (0.5, 4.3) 1.4 (0.5, 3.2)
Painful tongue 4.1 (0.4, 7.8) 1.3 (0.5, 6.4) 2.2 (0.4, 7.0)

a: Significantly different from pre-administration at P < 0.05 (Scheffe’s F test) (n = 21)

bVAS, visual analog scale; Median (1st quartile, 3rd quartile)